Detalhe da pesquisa
1.
Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment.
Gynecol Oncol
; 159(1): 88-94, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32747013
2.
Development of a multiparameter flow cytometric assay as a potential biomarker for homologous recombination deficiency in women with high-grade serous ovarian cancer.
J Transl Med
; 13: 239, 2015 Jul 22.
Artigo
Inglês
| MEDLINE | ID: mdl-26198537
3.
Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort.
Mol Cell Proteomics
; 12(6): 1621-31, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23449826
4.
Feasibility and safety of sequential research-related tumor core biopsies in clinical trials.
Cancer
; 119(7): 1357-64, 2013 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23280317
5.
L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer.
J Cell Mol Med
; 16(10): 2369-78, 2012 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-22333033
6.
Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome.
Cancer
; 118(6): 1543-53, 2012 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22009736
7.
Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers.
Gynecol Oncol
; 120(1): 5-10, 2011 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-20950846
8.
Phase I/Ib study of olaparib and carboplatin in heavily pretreated recurrent high-grade serous ovarian cancer at low genetic risk.
Oncotarget
; 10(30): 2855-2868, 2019 Apr 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31080557
9.
Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases in vitro toxicity of PARP inhibition by preventing Rad51 foci formation in BRCA wild type high-grade serous ovarian cancer.
Oncotarget
; 8(67): 111026-111040, 2017 Dec 19.
Artigo
Inglês
| MEDLINE | ID: mdl-29340034
10.
Phase I/Ib study of olaparib and carboplatin in women with triple negative breast cancer.
Oncotarget
; 8(45): 79175-79187, 2017 Oct 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29108297
11.
Sequence-Specific Pharmacokinetic and Pharmacodynamic Phase I/Ib Study of Olaparib Tablets and Carboplatin in Women's Cancer.
Clin Cancer Res
; 23(6): 1397-1406, 2017 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27663600
12.
Deregulation of the cyclin D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Cancer Res
; 63(18): 5674-8, 2003 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-14522882
13.
Allelic imbalance and altered expression of genes in chromosome 2q11-2q16 from rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Oncogene
; 22(8): 1253-60, 2003 Feb 27.
Artigo
Inglês
| MEDLINE | ID: mdl-12606953
14.
CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer.
Front Oncol
; 5: 123, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26082895
15.
Mammary gland carcinogenesis by food-derived heterocyclic amines and studies on the mechanisms of carcinogenesis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Mutat Res
; 506-507: 145-52, 2002 Sep 30.
Artigo
Inglês
| MEDLINE | ID: mdl-12351154
16.
Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses.
J Natl Cancer Inst
; 106(6): dju089, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24842883
17.
Vandetanib, designed to inhibit VEGFR2 and EGFR signaling, had no clinical activity as monotherapy for recurrent ovarian cancer and no detectable modulation of VEGFR2.
Clin Cancer Res
; 16(2): 664-72, 2010 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20068097
18.
Constitution and quantity of lysis buffer alters outcome of reverse phase protein microarrays.
Proteomics
; 7(22): 4066-8, 2007 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-17952872
19.
Gene expression profiling in the mammary gland of rats treated with 7,12-dimethylbenz[a]anthracene.
Int J Cancer
; 118(1): 17-24, 2006 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-16003757
20.
Global gene expression profiling of chemically induced rat mammary gland carcinomas and adenomas.
Toxicol Pathol
; 33(7): 768-75, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-16316942